INTRODUCTION
Dengue virus is a ssRNA virus belonging to the flavivirus family and is the causative agent associated with severe disease in humans, referred to as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). It is an arthropodborne virus using a mosquito vector, primarily Aedes aegypti for transmission to its host. Investigation into dengue virus pathogenesis has been hindered as a result of the lack of an acceptable animal model, as humans and nonhuman primates are the only known organisms susceptible to naturally occurring disease [1, 2] . Some recent progress has been made in the use of mouse models of dengue virus infection, which display characteristics of dengue virus infection in humans, including apoptosis [3] . Nevertheless, the majority of knowledge about dengue virus pathogenesis has been gained through in vitro studies as well as clinical and epidemiological evidence acquired from patients suffering from dengue virus infection in dengue endemic areas of the world, primarily South-East Asia, South America, and Africa. These studies have determined that dengue virus has the ability to induce apoptosis in a number of cells important to its pathogenesis or implicated therein {mono-cytes, lymphocytes, dendritic cells (DC), and endothelial cells [4 -10] }. However, the mechanisms responsible have not been completely elucidated. The study of dengue virus disease is confounded further by an intriguing immune-adapted phenomenon known as antibody-dependent enhancement (ADE). This relies on the presence of pre-existing antibodies to previous dengue virus infection (s) . This antibody-enhanced infection translates to increased infection of target cells, resulting in a more severe infection, potentially culminating in DHF/DSS in afflicted individuals [11] [12] [13] . Antibody-enhanced dengue virus infection has been linked to heightened production of vasoactive cytokines and chemokines, which have roles in the vascular dysfunction associated with severe dengue disease [14 -16] . Surprisingly, there are no previous studies investigating the effects of ADE on dengue virus-induced apoptosis of any target cell. In the present study, we report a dramatic sensitivity of mast cell-like KU812 and human mast cell 1 (HMC-1) to apoptosis triggered by antibody-enhanced dengue virus infection.
MATERIALS AND METHODS

Cell culture
Human KU812 cells [17] were maintained in RPMI 1640 (Sigma, Oakville, Ontario, Canada), supplemented with 10% FCS (Life Technologies, Grand Island, NY, USA) and 10 mM HEPES. HMC-1 cells [18] were maintained in IMDM, supplemented with 10% FCS. All cell lines were passaged two to three times per week. K562 cells were grown in RPMI 1640 supplemented with 5% FCS. U937 cells were grown in RPMI 1640, supplemented with 10% FCS.
DC isolation and culture
Peripheral blood (50 ml) was obtained from normal donors collected in sodium citrate vacutainer tubes and then diluted 1:1 in RPMI 1640 at room temperature. The mixture was then overlayed on Histopaque (Sigma) and centrifuged at 400 g for 30 min at room temperature. The PBMC band was collected and washed three times with RPMI 1640. Cells were resuspended in RPMI 1640, supplemented with 10% FCS, and incubated for 2 h in a 75-cm 2 flask at 37°C, 5% CO 2 . Media were removed, and adherent cells were washed twice to ensure removal of nonadherent cells before the addition of 12 ml RPMI 1640, supplemented with 10% FCS, 150 ng/ml GM-CSF, 150 ng/ml IL-4 (Cedarlane Labs, Burlington, Ontario, Canada), and 100 ng/ml polymyxin B sulfate (Sigma). The culture was fed every 2-3 days by replacing it with fresh media until Day 6, when nonadherent cells exhibiting a DC morphology were harvested for use.
Dengue virus propagation
Dengue virus, type 2 (strain 16681) [11] , was propagated in African green monkey kidney Vero cell monolayers, cultured in endotoxin-free RPMI 1640 (Sigma), supplemented with 1% FCS. In some cases, dengue virus was UVinactivated by exposure to a germicidal bulb at a distance of 10 cm for 10 min. The dsRNA analog polyinosinic:polycytidylic acid [poly(I:C); Sigma] was used from stock solution of 1 mg/ml, dissolved in sterile, distilled water.
Sera
For ADE assays of dengue virus infection, a dengue-immune serum pool was prepared by using nine convalescent-phase sera from patients recovering from a dengue virus serotype 2 infection. The individual dengue-convalescent patient sera were obtained from a collection provided by Dr. Bruce Innis (Armed Forces Research Institute of Medical Science, Bangkok, Thailand) and described briefly in ref. [19] .
Transfection conditions
KU812 cells (5ϫ10 6 ) were resuspended in 100 ul Nucleofector (Amaxa, Gaithersburg, MD, USA) and transfected with 5 ug DC-specific ICAM-grabbling nonintegrin receptor (SIGNR)/liver/lymph node (L)-SIGN cDNA [pcDNA3-DC-SIGNR, Cat. #6746, obtained from National Institutes of Health (NIH) AIDS Research and Reference Reagent Program, Bethesda, MD, USA]. Cells were maintained in RPMI 1640, supplemented with 10% FCS plus 1 mg/ml Geneticin (50 mg/ml stock; Invitrogen, Carlsbad, CA, USA) for stable transfection.
Infection conditions
Aliquots of dengue virus were incubated alone or in the presence of dengueimmune human serum for 60 min at 4°C. KU812, DC-SIGNR-transfected KU812, HMC-1, K562, and U937 cells were inoculated with dengue virus (with or without dengue-immune serum) at a multiplicity of infection (MOI) of 1-2 (as assayed on Vero cells). Following 90 min adsorption at 4°C, unadsorbed virus and antibody were removed by washing, and cells were resuspended in medium for incubation at 37°C. Mock infection was performed using Vero cell-conditioned RPMI-1640 media, supplemented with 1% FCS. Where indicated, 5 g/ml camptothecin (Sigma; 24 h incubation at 37°C) or 1 M sorbitol (Sigma; 2 h at 37°C followed by washout and incubation in normal medium for 4 h) treatment was used as a positive control for apoptosis induction.
Plaque assay
Supernatants from dengue virus-infected Vero or KU812 cells were harvested, serially diluted, and inoculated onto Vero cell monolayers for plaque assay. At 30 h postinfection, cells were washed once with PBS, fixed with methanol for 10 min, and then placed at 4°C in PBS until immunostaining, which was performed using dengue-specific antibody and goat anti-human alkaline phosphatase (AP) conjugate followed by development with the one-step nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate AP developer (Pierce, Rockford, IL, USA). 
Caspase inhibition
Cycloheximide inhibition
Following dengue virus adsorption, cells were resuspended in fresh RPMI 1640 containing 1% FCS, with or without 0.1 g/ml cycloheximide (Sigma) for 24 h.
DNA fragmentation analysis
DNA from KU812 cell cultures was extracted by the Hirt procedure [20] and subjected to electrophoresis on 1.5% agarose gels. A 6-h, 1-M sorbitol (Sigma) treatment was used as a positive control for apoptosis induction.
FACS analysis
Cells were harvested at indicated times postinfection, fixed in 4% paraformaldehyde, permeabilized using 0.1% saponin, and stained for intracellular expression of dengue envelope (E) protein using mAb 1B7 [21] , nonstructural 1 (NS1) protein using mAb 7E11 [22] , or an IgG2a isotype control antibody. A goat anti-mouse Alexa 488 conjugate (Molecular Probes, San Diego, CA, USA) was used as a secondary antibody. Washed cells were resuspended in 1% paraformaldehyde and subjected to analysis using a FACScalibur flow cytometer (Becton Dickinson, San Jose, CA, USA). Data were analyzed using FCS Express 3 and CellQuest. AnnexinV-Alexa 647 conjugate (Molecular Probes) was used to determine phosphatidylserine (PS) exposure. Propidium iodide (PI; 2 g/ml) was used to observe late apoptotic/necrotic cells. Analysis for expression of DC-SIGNR/L-SIGN (CD299) or DC-SIGN was performed using anti-DC-SIGNR antibody (#11423; NIH) or anti-DC-SIGN antibody (designated 120507; Abcam, Inc., Cambridge, MA), respectively.
Receptor blockade
Anti-Fc␥RII (CD32) antibody was used as described previously [23] .
Western blot
Cells were harvested at indicated times postinfection, washed in 1ϫ PBS, and resuspended in 60 l dissociation buffer. The total sample (15 l) was loaded per well and separated using 15% SDS-PAGE. Protein was then transferred to polyvinylidene difluoride by semidry transfer. Blots were blocked in TBST (0.1%) ϩ 5% nonfat milk, washed, and probed using the specified antibodies, and antibodies against caspases 7-9 were from Cell Signaling Technologies (Danvers, MA, USA). Anti-poly-ADP-ribose polymerase 1 (anti-PARP-1) antibody was from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-D4-guanosine diphosphate dissociation inhibitor (anti-D4-GDI) antibody was from Imgenex (San Diego, CA, USA).
RESULTS
Antibody-enhanced dengue virus infection of KU812 cells results in DNA fragmentation
We have shown previously that the KU812 prebasophil/mast cell line is susceptible to antibody-enhanced dengue virus infection [15, 16] . We now report that antibody-enhanced infection leads to dramatic apoptosis of these cells. This was established initially through analysis of DNA fragmentation following infection by dengue virus. It was found that only cells infected with dengue virus in the presence of subneutralizing concentrations (1:1000 and 1:10,000) of convalescent dengue patient sera resulted in DNA fragmentation (Fig. 1A) . Treatment with 1 M sorbitol is shown as a positive control for apoptosis induction compared with untreated cells (Fig. 1B) .
Antibody-enhanced dengue virus infection leads to productive infection and apoptosis in two separate subpopulations of KU812 cells
Further confirmation of apoptosis was obtained using flow cytometry to analyze cells for the presence of dengue virus E protein, a prominent structural viral protein, and cell membrane-externalized PS, a well-characterized indicator of apoptosis. Interestingly, we found that cells expressing dengue virus E protein remained viable, and Annexin V (ϩ) cells undergoing apoptosis lacked any detectable level of dengue E protein ( Fig. 2A) at 24 h postinfection. Cells were also probed for the dengue virus NS1 protein and with dengue immune mouse serum confirming the lack of double-positive, stained cells showing viral protein expression and PS exposure (data not shown). Cells were also analyzed using confocal microscopy, further confirming the presence of these two distinct populations of cells (Fig. 2B ). Twenty-four hour treatment with 5 g/ml camptothecin provided a positive control for apoptosis induction.
Induction of apoptosis following antibodyenhanced dengue virus infection is cell typespecific
The ability of dengue virus to induce apoptosis of additional target cells following antibody-enhanced infection was investigated. In addition to KU812 cells, the FcR-bearing cell lines K562, U937, and HMC-1 were used as host target cells. All are known to express Fc␥RII and exhibit ADE virus infection [15, 24, 25] . Cells were mock-infected or infected with dengue virus and a subneutralizing concentration (1:10,000) of dengueimmune patient sera. Cells were analyzed at 24 h and 48 h postinfection by flow cytometry for apoptosis, as determined by Annexin V binding to externalized PS and detection of dengue virus E protein (Fig. 3, A and B) or NS1 protein (Fig. 3 , C and D), indicative of infection. There were no notable mean fluorescence intensity differences between cell types stained for E or NS1 protein. Plaque assays were also performed on supernatants collected at 0, 24, and 48 h postinfection (Table 1) , further confirming active dengue virus infection and the pro- duction of infectious virus, despite the differences in the amount of virus produced between cell types. There was no positive E protein staining of cells at the 0-h time-point (Fig.  3E) , immediately following adsorption, indicating that E protein detected at 24 h and 48 h (Fig. 3, A and B) is from newly produced E protein and not a remnant of the initial virus inoculum. A noticeable loss of total E protein staining occurred for infected KU812 cells from 24 h to 48 h, and the level of total NS1 protein staining varied slightly. This decrease in structural E protein staining may be a result of virus shedding. Interestingly, the NS1 protein-staining profile changes dramatically from 24 h to 48 h, and the majority of NS1ϩ cells is viable at 24 h postinfection (Fig. 3C ) compared with the majority of NS1ϩ cells becoming apoptotic by 48 h postinfection (Fig. 3D ). This may suggest that at least some apoptotic cells were productively infected. KU812 cells exhibited the most dramatically increased level of apoptosis by 24 h following infection (46.5Ϯ17.5 Annexin Vϩ DenϩAb compared with 6.9Ϯ2.2 mock; PϽ0.05; Fig. 3A ). Apoptosis induction in HMC-1 was not as rapid as that observed in dengue virusinfected KU812 cells, with the greatest increase in Annexin V-positive cells occurring by 48 
Antibody-enhanced binding through Fc␥RII is required for dengue infection and apoptosis of KU812 cells
In the absence of dengue-immune serum, KU812 cells are poorly susceptible to dengue virus infection (Fig. 4, D2 alone) . In the presence of subneutralizing dengue-immune serum, KU812 cells showed dramatic infection and apoptosis, both of which were blocked by pretreatment of cells with anti-Fc␥RII antibody (Fig. 4) . Additionally, UV-inactivated virus with subneutralizing dengue-immune serum did not result in infection or apoptosis.
Antibody-enhanced dengue virus-induced apoptosis requires replication-competent virus; virus binding and internalization are not sufficient
We have shown previously that antibody-enhanced dengue virus infection of KU812 cells peaks at 24 h postinfection [23] 
inactivation was used to render the dengue virus particles replication incompetent. Cells were analyzed for Annexin V binding as well as PI exclusion to discriminate early apoptotic cells (AnnVϩ/PI-) from late apoptotic/necrotic cells (AnnVϩ/PIϩ). UV-inactivated virus, with or without dengue immune serum, was unable to induce apoptosis of KU812 cells (Fig. 5A) . This indicates that a certain level of genomic integrity is required for apoptosis induction. As the dsRNA analog poly(I:C) has been shown to induce apoptosis in dsRNA-sensitive cells [26, 27] , cells were treated with increasing amounts to determine if perhaps an innate immune response mediated by a dsRNA sensor may be responsible; however, we found that the presence of poly(I:C) was not sufficient to induce apoptosis (Fig.  5A) .
As a control, we confirmed that UV-inactivated virus particles underwent antibody-enhanced binding in the same manner as non-UV-inactivated virus particles, by using a binding assay using 35 S-labeled dengue virus as described previously [23] . Autoradiography of dengue virus bound to KU812 cells demonstrated that the level of virus binding was similar, indicating that UV inactivation does not affect antibody-enhanced binding of dengue virus to KU812 cells (Fig. 5B) .
Additional experiments performed using combinations of UV-inactivated virus, dengue immune serum, and poly(I:C) showed no effects on cell viability (data not shown). Also, addition of 0.1 g/ml cycloheximide, an inhibitor of protein synthesis, to KU812 cells immediately following virus adsorption, was able to block apoptosis (Fig. 5C ). When cycloheximide was added at 4 h or 6 h postadsorption, blockade of apoptosis was less effective (data not shown). These results suggest that the presence of native dengue virus-derived dsRNA and/or synthesis of a specific virus protein(s) may be responsible for apoptosis induction.
Antibody-enhanced dengue virus-induced apoptosis of KU812 cells is caspase-dependent
We wished to determine if the inhibition of caspase activity would prevent apoptosis induced by antibody-enhanced dengue virus infection of KU812 cells. Following virus adsorption, cells were treated with a 50-M concentration of broad or selective inhibitors of caspases including the broad caspase inhibitor (z-VAD), caspase 8 inhibitor (z-IETD), caspase 9 inhibitor (z-LEHD), and caspases 3 and 7 inhibitor (z-DEVD). Effectiveness of the caspase inhibitors was verified using camptothecin-induced apoptosis as a reference control (data not shown) and by Western blotting as indicated below. At 24 h postinfection, cells were harvested and subsequently analyzed for Annexin V binding as well as PI exclusion. Treatment with the broad-spectrum caspase inhibitor (z-VAD) was the most effective, significantly decreasing the level of dengue virusinduced apoptosis (Fig. 6A) . Importantly, treatment with this broad caspase inhibitor had no effect on dengue virus E protein expression (Fig. 6B ) or on infectious virus production as determined by plaque assay (data not shown). The more selective caspase inhibitors resulted in varied amounts of inhibition (Fig. 6A) .
Antibody-enhanced dengue virus infection results in cleavage of initiator caspases 8 and 9
We performed a time-course analysis of KU812 cells for evidence of cleavage of the initiator caspases (caspases 8 and 9) from their zymogen procaspase forms to active caspases following antibody-enhanced dengue virus infection by Western blot analysis (Fig. 7A) . It was found that cleavage of caspases 8 and 9 occurred as early as 12 h postinfection. This confirmed that the classical intrinsic and extrinsic caspase pathways become activated following antibody-enhanced dengue virus infection.
To further investigate caspase cleavage, the broad and selective caspase inhibitors mentioned previously were used. The inhibitors were added to cells at a concentration of 50 M following virus adsorption, with cells harvested and analyzed at 24 h postinfection. Western blot analysis showed almost complete inhibition of caspase 8 cleavage with the use of the broad caspase inhibitor (z-VAD) and the specific caspase 8 inhibitor (z-IETD; Fig. 7B ). On the other hand, the caspases 3 and 7 inhibitor (z-DEVD) resulted in only slight inhibition. Analysis of caspase 9 cleavage showed the appearance of an unknown cleavage product. Although treatment with selective and broad caspase inhibitors was able to prevent the appearance of this unknown cleavage product, the levels of the established cleavage products for caspase 9 (p35/37) were unaffected.
Effector caspase activation and cleavage of caspase substrates following dengue virus infection are prevented by caspase inhibition Cleavage and activation of the effector caspase 7, in addition to cleavage of the well-known caspases 3 and 7 substrates PARP and D4-GDI, were also analyzed by Western blot. The greatest inhibition of caspase 7 cleavage was observed with the broadspectrum caspase inhibitor (z-VAD), almost completely preventing the appearance of the p20 fragment. Cleavage of PARP and D4-GDI was found to occur, demonstrating functional caspases 3 and 7 activity following antibody-enhanced dengue virus infection (Fig. 8) . Treatment of cells with camptothecin, an inducer of apoptosis, provided a positive control for cleavage of D4-GDI. Addition of the broad-spectrum caspase inhibitor (z-VAD) was sufficient to prevent cleavage of PARP and D4-GDI. The specific inhibitors for caspases 3 and 7 (z-DEVD) and caspase 8 (z-IETD) were able to decrease the cleavage of PARP and D4-GDI compared with untreated cells but to a lesser extent than the broad inhibitor (z-VAD). This was expected, as the broad caspase inhibitor z-VAD blocks the activation of the upstream protease cascade during the apoptotic process, whereas z-DEVD acts specifically downstream as a competitive inhibitor for the caspase 3 cleavage site.
L-SIGN/DC-SIGNR expression overcomes the requirement for antibody enhancement of dengue virus infection and apoptosis
With the knowledge that DC-SIGN is the receptor for dengue virus on DC [22, 28] and that its homologue L-SIGN/DC-SIGNR has also been shown to mediate dengue infection, we investigated whether L-SIGN could substitute for FcR and dengue-specific antibody as a functional receptor mediating dengue virus infection or apoptosis in KU812 cells. Following transfection of a DC-SIGNR expression plasmid, KU812 cells were stained for surface expression compared against normal KU812 cells (Fig. 9A) , which were also negative for DC-SIGN expression, with positive staining shown on monocyte-derived DC (Fig. 9A) . Normal KU812 cells and KU812 cells expressing L-SIGN were inoculated with dengue virus, with and without subneutralizing concentration of dengue-immune serum. In contrast to normal KU812 cells, L-SIGN-expressing KU812 cells were infectable with dengue virus in the absence of dengue-immune serum ( Fig. 9B; Den alone) . Interestingly, L-SIGN transfection also rendered KU812 cells susceptible to dengue virus-induced apoptosis in the absence of dengue immune serum ( Fig. 9B ; Den alone). When L-SIGN-expressing KU812 cells were infected with dengue virus and the subneutralizing concentration of dengue-immune serum, there was an additive effect, particularly with regard to apoptosis (30 -60% Annexin V single-positive, Fig. 9B ), which was abrogated with anti-Fc␥RII-blocking antibody. Thus, L-SIGN/DC-SIGNR is able to substitute for Fc␥RII in mediating dengue infection and apoptosis of KU812 cells.
DISCUSSION
In this study, we provide the first evidence for induction of apoptosis in antibody-enhanced dengue virus infection in mast cell/basophil-like KU812 and HMC-1 cells. KU812 and HMC-1 as well as cord blood-derived mast cells have been shown recently to support antibody-enhanced dengue virus infection mediated primarily through Fc␥RII [23] . Mast cells are prominent in the skin (the initial site of dengue infection) [29, 30] as well as surrounding blood vessels and are capable of producing vasoactive mediators, such as histamine and inflammatory factors {including IL-1␤, IL-6, CCL5 (RANTES), CXCL10 (IFN-induced protein-10), CCL3/CCL4 (MIP-1␣/␤) [15, 16] }. Although it is well-known that mast cell degranulation results in the release of a variety of vasoactive (i.e., histamine) and cytotoxic granules (i.e., granzyme B), it is important to note that in our studies of antibody-enhanced dengue virus infection of mast cell-like cells, we do not observe any degranulation as determined by ␤-hexosaminidase release assay but rather release of a specific profile of secreted cytokines and chemokines [16] . Taken together with other evidence for mast cell involvement in dengue pathogenesis [31] [32] [33] [34] [35] [36] [37] , the results of the present study indicate multiple mechanisms of mast cell dysregulation by dengue virus.
Dengue virus-induced apoptosis has been shown in vivo, specifically in CD8ϩ T cells, as well as in liver hepatocytes and Kupffer cells from dengue-infected patients [6, 38] . Apo- ptosis has also been documented in in vitro dengue virusinfected cells, including human hepatoma cells, neuroblastoma cells, DC, endothelial cells, and monocytes [4, 7, 9, 39] ; however, a clear-cut, cellular mechanism for dengue virusinduced apoptosis remains to be determined.
Our finding that dengue-mediated apoptosis of KU812 cells primarily affects bystander cells is intriguing. We propose two possible mechanisms for this observation. The first mechanism involves induction of apoptosis early in virus infection with rapid shut-down of further viral gene expression. The second mechanism involves virus-triggered release of soluble mediators of apoptosis, which then act on uninfected neighboring cells. We have eliminated several candidate soluble mediators of apoptosis, e.g., Fas ligand, TNF-␣, and lymphotoxin-␣ (data not shown). In addition, KU812 cells are reported to be resistant to TRAIL-mediated apoptosis [40] . Although TRAIL has been shown to be up-regulated in dengue virus-infected hepatoma cells as well as in infected HUVECs, TRAIL induces apoptosis only in the infected hepatoma cells. A possible explanation is that the receptor repertoire may vary between these cell types. There exist a number of receptors for TRAIL, including decoys, which would affect the availability of TRAIL to initiate a proapoptotic signal. Additionally, the intracellular action of pro-and antiapoptotic proteins can greatly influence sensitivity to a proapoptotic ligand such as TRAIL. The mechanism of bystander apoptosis in KU812 cells is an important subject for ongoing investigation.
In our study, promiscuous caspase activation was found to be a prominent feature of antibody-enhanced dengue infection of KU812 cells. Of these, the inhibitor for the effector caspases 3 and 7 (z-DEVD), the hub of caspase activation, and execution responsible for the downstream actions of the caspase cascade provided the greatest level of protection from apoptosis. Inhibition of either of the initiator caspases 8 (extrinsic) and 9 (intrinsic), although able to decrease the level of apoptosis significantly, was not sufficient to prevent apoptosis. Moreover, caspases 8 and 9 underwent cleavage at similar time-points. These results indicate that antibody-enhanced, dengue virusinduced apoptosis is a caspase-dependent process with roles for the intracellular and extracellular arms of the caspase pathway. This stands in contrast to examples of antibodyindependent dengue infection of cells such as neuroblastoma [41] and Hela cells [42, 43] , which implicated specific caspases as major apoptotic mediators. For example, caspases 6 and 9 were found to play a dominant role in dengue-mediated apoptosis of neuroblastoma cells [41] . In contrast, a role for caspase 3 but not caspase 9 has been inferred from overexpressed dengue virus M protein-mediated apoptosis of HeLa cells [42, 43] . Furthermore, studies with another flavivirus, West Nile virus (WNV), have implicated cleavage and activation of caspase 8 in apoptosis mediated by virus protease (NS3) [44] . NS3 has also been implicated in dengue virus-mediated apoptosis of Vero cells [45] .
The study of the mechanisms involved in virus-induced apoptosis is complicated as a result of the intricate relationship between virus infection and the host innate immune response. Apoptosis may result from the action of proapoptotic viral/ virus-induced proteins and/or triggering of innate pathogen recognition receptors for products of virus replication (ssRNA or dsRNA) including TLR3, -7, or -8, dsRNA-activated protein kinase receptor (PKR), retinoic acid-inducible gene I (RIG-I), and melanoma differentiation-associated gene-5 (MDA-5), leading to antiviral responses, including type I IFN production [26, 27, 46 -48] . Investigation of WNV infection in a mouse model found that detection of dsRNA by TLR3 led to increased inflammation and breakdown of the blood-brain barrier in a TNFRI-dependent manner, indicative of apoptosis [49] . Bovine viral diarrhea virus, another flavivirus, has been shown to induce apoptosis of cells via PKR [50] . Recently, the flaviviruses have been shown to up-regulate mRNA expression for RIG-I and MDA-5 [51] . It has also been demonstrated that flavivirus infection triggers IFN production via a RIG-I-dependent mechanism [52] . Whether these responses play a role in dengue virus-induced apoptosis remains to be resolved.
Treatment of KU812 cells with the dsRNA analog poly(I:C) was found not to induce apoptosis in our study, arguing against a role for external or endosomal dsRNA as an apoptotic trigger. This is in agreement with other studies using poly(I:C) in the context of antiviral responses mediated by TLR3 [53, 54] . Mast cells can detect extracellular dsRNA via TLR3, leading to a transcriptional increase and release of IFN-␣/␤. Importantly, responses to external or endosomal poly(I:C) do not result in mast cell degranulation or changes in cell viability [53] . It is unknown whether intracellular dsRNA sensors (RIG-I, MDA-5, PKR) triggered by interaction with de novo-produced viral dsRNA during infection, transfected poly(I:C), or native dsRNA sequences could interface with apoptotic machinery, resulting in cell death. Recent evidence suggests this may be the case [55] .
Our observation that L-SIGN/DC-SIGNR can replace Fc␥RII and dengue-specific antibody for dengue virus infection and apoptosis of KU812 cells illustrates the idea that apoptosis induction is not absolutely dependent on a specific virus receptor. Nevertheless, for normal KU812 cells, the absence of L-SIGN coupled with the presence of Fc␥RII suggests a role for ADE in dengue virus infection and associated apoptosis. Moreover, our report is the first to show that cells lacking known dengue virus receptors DC-SIGN or L-SIGN but supporting infection via FcR are susceptible to dengue virusmediated apoptosis.
